🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ixazomib citrate works in treating pat...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2012-01-31
Trial ID
NCT01415882
Treatments Being Tested
The main aim of this study is to learn if ixazomib, given with dexamethason...
Status
Completed
Location
Highlands Oncology Group
Start Date
2017-08-01
Trial ID
NCT03170882
Treatments Being Tested
This study is the first study of tasquinimod, an inhibitor of S100A9, in pa...
Status
Terminated
Location
University of Pennsylvania
Start Date
2020-07-10
Trial ID
NCT04405167
Treatments Being Tested
The purpose of this study is to determine the overall response rate of pati...
Status
Terminated
Location
UCSD Moores Cancer Center
Start Date
2018-10-17
Trial ID
NCT03590652
This phase II trial studies how well daratumumab, bortezomib, and dexametha...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-01-17
Trial ID
NCT03763162
Treatments Being Tested
Some patients with antibody-mediated autoimmune hematological diseases (war...
Status
Withdrawn
Location
Mahevas
Start Date
2019-09-01
Trial ID
NCT03965624
Treatments Being Tested
This is an open-label, multicenter, sequential, 5-arm, phase 1 study of ora...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-10
Trial ID
NCT01454076
The goal of this clinical research study is to evaluate the safety and effe...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2014-09
Trial ID
NCT02206425
Treatments Being Tested
The purpose of this study is to provide continued access of ixazomib and/or...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2012-12-26
Trial ID
NCT01659658
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ixazomib ci...
Status
Unknown
Location
Emory University/Winship Cancer Institute
Start Date
2016-03-01
Trial ID
NCT02632396